Shin Nippon Biomedical Laboratories, Ltd.

2395.T
Diagnostics & Research
2026/11/10 14:08 Updated
Market Cap: $320.4M (¥50.6B)
Stock Price: $7.70 (¥1,216)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Distribution of Surplus (Interim Dividend)

Based on a policy of stable dividends to shareholders, the company resolved an interim dividend of 20 yen per share with record date September 2026 and payment date November 30, 2026. The same amount is planned for the interim dividend for the fiscal year ending March 2027. Total dividends amount to 832 million yen.

Importance:
Page Updated: November 10, 2026
IR Disclosure Date: November 10, 2026

Key Figures

  • Dividend per share: 20 yen00 sen
  • Total dividends: 832 million yen
  • Record date: September 30, 2026

AI要約

Dividend Policy and This Interim Dividend

The Company recognizes stable returns to shareholders as an important management policy, and determines dividends considering fundamental earning power and cash flow with a consolidated dividend payout ratio target of 30–40%. For this interim dividend with record date September 2026, we have decided on 20 yen per share, with total dividends of 832 million yen and payment date of 2026-11-30.

Outlook and Annual Dividend Breakdown

The annual dividend breakdown is assumed to be 30 yen at the end of Q2 and 20 yen at year-end (total 50 yen). The interim dividend for the fiscal year ending March 2027 is also planned at 20 yen, with a year-end dividend of 50 yen, and the full-year outlook is 20 yen/20 yen/50 yen.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shin Nippon Biomedical Laboratories, Ltd.

Company overview · Stock price · Financial data · All IR

View company page →